Articoli anno 2001

High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis
Gimenez-Barcons M, Franco S, Suarez Y, Forns X, Ampurdanes S, Puig-Basagoiti F, Sanchez-Fueyo A, Barrera JM, Llovet JM, Bruix J, Sanchez-Tapias JM, Rodes J, Saiz JC.
Liver Unit, Institut de Malalties Digestives, Departament de Medicina, IDIBAPS, Hospital Clinic, University of Barcelona, Spain.
Hepatology 2001 Jul;34(1):158-67

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G.
Istituto di Medicina Interna e Geriatria, Universita Cattolica del Sacro Cuore, Roma, Italy.
Cancer 2001 Jul 1;92(1):126-35

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma
Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P.
Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China. mok206551@cuhk.edu.hk
Cancer 2001 Jun 15;91(12):2369-77

Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt
Nol W, Schindler CG, Figulla HR, Wuttke W, Hufner M, Hartmann H, Ramadori G.
Department of Medicine, Georg-August-Universitat, Gottingen, Germany.
J Hepatol 2001 Jun;34(6):818-24

Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study
Ikeda K, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Arase Y, Murashima N, ChayamaK,Kumada H.
Department of Gastroenterology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan. ikedakenji@tora.email.ne.jp
J Gastroenterol Hepatol 2001 Apr;16(4):406-15

Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis
Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J.
Digestive Diseases Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Spain.
Am J Gastroenterol 2001 Apr;96(4):1160-3

Expression of c-myc promoter binding protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis and human hepatocellular carcinoma.
Fan X, Solomon H, Schwarz K, Kew MC, Ray RB, Di Bisceglie AM.
Department of Internal Medicine, St. Louis University School of Medicine, Missouri 63110-0250, USA.
Dig Dis Sci 2001 Mar;46(3):563-6

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development
Benvegnù L, Noventa F, Bernardinello E, Pontisso P, Gatta A, Alberti A.
Department of Clinical and Experimental Medicine, Clinica Medica 5, University of Padova, Italy.
Gut 2001 Jan;48(1):110-5

Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation
Izumi N, Asahina Y, Noguchi O, Uchihara M, Kanazawa N, Itakura J, Himeno Y,
Miyake S, Sakai T, Enomoto N
Division of Gastroenterology and Hepatology, Musashino Red-Cross Hospital,
Tokyo, Japan. Cancer2001 Mar

Hepatitis c virus protein expression induces apoptosis in hepg2 cells
Kalkeri G, Khalap N, Garry RF, Fermin CD, Dash S
Department of Pathology and Laboratory Medicine, Department of Microbiology and Immunology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, Louisiana, 70112
Virology 2001 Mar30

Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients
Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, Roffi L, Redaelli A, Rossini A, Spinzi G, Minoli G.
Department of Pathology, Valduce Hospital, Como, Italy.
Am J Gastroenterol 2001 May;96(5):1575-80

Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins
Machida K, Tsukiyama-Kohara K, Seike E, Tone S, Shibasaki F, Shimizu M, Takahashi H, Hayashi Y, Funata N, Taya C, Yonekawa H, Kohara M.
Department of Microbiology and Cell Biology, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613, Japan.
J Biol Chem 2001 Apr

Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients
Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N.
Second Department of Surgery, Shimane Medical University, Izumo, Japan.
Cancer 2001 Jun 15;91(12):2378-85

Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma
Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS.
Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Gastroenterology 2001 Sep;121(3):699-709

High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity
Donato MF, Arosio E, Ninno ED, Ronchi G, Lampertico P, Morabito A, Balestrieri MR, Colombo M.
Division of Hepatology, IRCCS Maggiore Hospital, Milan, Italy.
Hepatology 2001

Home

Chi siamo Faq Links Reviews News E-mail Casi clinici Immagini